Neuraminidase is a host-directed approach to regulate neutrophil responses in sepsis and COVID-19

Detalhes bibliográficos
Autor(a) principal: Formiga, Rodrigo de Oliveira
Data de Publicação: 2022
Outros Autores: Amaral, Flávia C., Souza, Camila F., Mendes, Daniel A. G. B., Wanderley, Carlos W. S., Lorenzini, Cristina B., Santos, Adara A., Antônia, Juliana, Farias, Lucas F., Natale, Caio C., Paula, Nicholas M., Silva, Patricia C. S., Fonseca, Fernanda R., Aires, Luan, Heck, Nicole, Starick, Márick R., Queiroz-Junior, Celso M., Santos, Felipe R. S., Souza, Filipe R. O. de, Costa, Vivian, Morrto, Alexandre, Van Weyenbergh, Johan, Sordi, Regina, Silva, Frederico Alisson, Cunha, Fernando Q., Rocha, Edroaldo L., Chollet-Martin, Silvie, Hurtado-Nedelec, Maria Margarita, Martin, Clémence, Burgel, Pierre-Régis, Mansur, Daniel S., Maurici, Rosemeri, Macauley, Matthew S., Báfica, André, Witko-Sarsat, Véronique, Spiller, Fernando
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/58090
Resumo: Universidade Federal de Santa Catarina. Departamento de Farmacologia. Florianópolis, SC, Brasil / Université de Paris, Institut Cochin, INSERM U1016, CNRS, Paris, France / Universidade Federal de Santa Catarina. Departamento de Imunobiologia, Parasitologia e Microbiologia. Florianóplis, SC, Brasil.
id CRUZ_907a006cc98a0264d7a458a9452eb26a
oai_identifier_str oai:www.arca.fiocruz.br:icict/58090
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Formiga, Rodrigo de OliveiraAmaral, Flávia C.Souza, Camila F.Mendes, Daniel A. G. B.Wanderley, Carlos W. S.Lorenzini, Cristina B.Santos, Adara A.Antônia, JulianaFarias, Lucas F.Natale, Caio C.Paula, Nicholas M.Silva, Patricia C. S.Fonseca, Fernanda R.Aires, LuanHeck, NicoleStarick, Márick R.Queiroz-Junior, Celso M.Santos, Felipe R. S.Souza, Filipe R. O. deCosta, VivianMorrto, AlexandreVan Weyenbergh, JohanSordi, ReginaSilva, Frederico AlissonCunha, Fernando Q.Rocha, Edroaldo L.Chollet-Martin, SilvieHurtado-Nedelec, Maria MargaritaMartin, ClémenceBurgel, Pierre-RégisMansur, Daniel S.Maurici, RosemeriMacauley, Matthew S.Báfica, AndréWitko-Sarsat, VéroniqueSpiller, Fernando2023-04-30T14:53:39Z2023-04-30T14:53:39Z2022FORMIGA, Rodrigo de Oliveira et al. Neuraminidase is a host-directed approach to regulate neutrophil responses in sepsis and COVID-19. British Pharmacological Society, p. 1-22, 2023.1476-5381https://www.arca.fiocruz.br/handle/icict/5809010.1111/bph.16013engBritish Pharmacological SocietyCOVID-19SARS-CoV-2SepsisMetalloproteinase-9NeuraminidaseNeutrófiloÁcido siálicoZanamivirOseltamivirSepseCOVID-19Metalloproteinase-9NeuraminidaseNeutrophilSARS-CoV-2Sialic acidZanamivirOseltamivirSepsisNeuraminidase is a host-directed approach to regulate neutrophil responses in sepsis and COVID-19info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleUniversidade Federal de Santa Catarina. Departamento de Farmacologia. Florianópolis, SC, Brasil / Université de Paris, Institut Cochin, INSERM U1016, CNRS, Paris, France / Universidade Federal de Santa Catarina. Departamento de Imunobiologia, Parasitologia e Microbiologia. Florianóplis, SC, Brasil.Universidade Federal de Santa Catarina. Departamento de Farmacologia. Florianópolis, SC, Brasil / Universidade Federal de Santa Catarina. Departamento de Imunobiologia, Parasitologia e Microbiologia. Florianóplis, SC, Brasil.Universidade Federal de Santa Catarina. Departamento de Farmacologia. Florianópolis, SC, Brasil.Universidade Federal de Santa Catarina. Departamento de Farmacologia. Florianópolis, SC, Brasil / Universidade Federal de Santa Catarina. Departamento de Imunobiologia, Parasitologia e Microbiologia. Florianóplis, SC, Brasil.Universidade de São Paulo. Escola de Medicina de Ribeirão Preto. Departamento de Farmacologia. Ribeirão Preto, SP, Brasil.Universidade Federal de Santa Catarina. Departamento de Farmacologia. Florianópolis, SC, Brasil / Universidade Federal de Santa Catarina. Departamento de Imunobiologia, Parasitologia e Microbiologia. Florianóplis, SC, Brasil.Universidade Federal de Santa Catarina. Departamento de Farmacologia. Florianópolis, SC, Brasil / Universidade Federal de Santa Catarina. Departamento de Imunobiologia, Parasitologia e Microbiologia. Florianóplis, SC, Brasil.Universidade Federal de Santa Catarina. Departamento de Farmacologia. Florianópolis, SC, Brasil.Universidade Federal de Santa Catarina. Departamento de Farmacologia. Florianópolis, SC, Brasil.Universidade Federal de Santa Catarina. Departamento de Farmacologia. Florianópolis, SC, Brasil / Universidade Federal de Santa Catarina. Departamento de Imunobiologia, Parasitologia e Microbiologia. Florianóplis, SC, Brasil.Universidade Federal de Santa Catarina. Departamento de Farmacologia. Florianópolis, SC, Brasil / Universidade Federal de Santa Catarina. Departamento de Imunobiologia, Parasitologia e Microbiologia. Florianóplis, SC, Brasil.Universidade Federal de Santa Catarina. Departamento de Farmacologia. Florianópolis, SC, Brasil.Universidade Federal de Santa Catarina. Departamento de Clínica Médica. Florianópolis, SC, Brasil.Universidade Federal de Santa Catarina. Departamento de Farmacologia. Florianópolis, SC, Brasil / Universidade Federal de Santa Catarina. Departamento de Imunobiologia, Parasitologia e Microbiologia. Florianóplis, SC, Brasil.Universidade Federal de Santa Catarina. Departamento de Farmacologia. Florianópolis, SC, Brasil / Universidade Federal de Santa Catarina. Departamento de Imunobiologia, Parasitologia e Microbiologia. Florianóplis, SC, Brasil.Universidade Federal de Santa Catarina. Departamento de Farmacologia. Florianópolis, SC, Brasil / Universidade Federal de Santa Catarina. Departamento de Imunobiologia, Parasitologia e Microbiologia. Florianóplis, SC, Brasil.Universidade Federal de Minas Gerais. Instituto de Ciências Biológicas. Departamento de Morfologia. Belo Horizonte, MG, Brasil.Universidade Federal de Minas Gerais. Instituto de Ciências Biológicas. Departamento de Bioquímica e Imunologia. Belo Horizonte, MG, Brasil.Universidade Federal de Minas Gerais. Instituto de Ciências Biológicas. Departamento de Morfologia. Belo Horizonte, MG, Brasil.Universidade Federal de Minas Gerais. Instituto de Ciências Biológicas. Departamento de Morfologia. Belo Horizonte, MG, Brasil.Hospital Naval Marcilio Dias. Instituto de Pesquisa Biomédica. Laboratório de Biologia Molecular. Rio de Janeiro, RJ, Brasil.Universidade Federal do Rio de Janeiro. Faculdade de Medicina. Laboratório de Pesquisa em Tuberculose. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunoparasitologia. Rio de Janeiro, RJ, Brasil.Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory for Clinical and Epidemiological Virology, KU Leuven, Leuven, Belgium.Universidade Federal de Santa Catarina. Departamento de Farmacologia. Florianópolis, SC, Brasil.Universidade Federal do Rio de Janeiro. Instituto de Microbiologia Paulo de Góes. Departamento de Imunologia. Rio de Janeiro, RJ, Brasil.Universidade de São Paulo. Escola de Medicina de Ribeirão Preto. Departamento de Farmacologia. Ribeirão Preto, SP, Brasil.Universidade Federal de Santa Catarina. Departamento de Farmacologia. Florianópolis, SC, Brasil / Universidade Federal de Santa Catarina. Departamento de Imunobiologia, Parasitologia e Microbiologia. Florianóplis, SC, Brasil.Universidade Federal de Santa Catarina. Departamento de Farmacologia. Florianópolis, SC, Brasil / Universidade Federal de Santa Catarina. Departamento de Imunobiologia, Parasitologia e Microbiologia. Florianóplis, SC, Brasil.INSERM-U1149, Faculté de Médecine, Site Xavier Bichat, CNRS, Université de Paris, Paris, France.Université de Paris, Institut Cochin, INSERM U1016, CNRS, Paris, France / Department of Pneumology, AP-HP, Hôpital Cochin, Paris, France.Université de Paris, Institut Cochin, INSERM U1016, CNRS, Paris, France / Department of Pneumology, AP-HP, Hôpital Cochin, Paris, France.Universidade Federal de Santa Catarina. Departamento de Farmacologia. Florianópolis, SC, Brasil / Universidade Federal de Santa Catarina. Departamento de Imunobiologia, Parasitologia e Microbiologia. Florianóplis, SC, Brasil.Universidade Federal de Santa Catarina. Departamento de Clínica Médica. Florianópolis, SC, Brasil.Department of Chemistry, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.Universidade Federal de Santa Catarina. Departamento de Imunobiologia, Parasitologia e Microbiologia. Florianóplis, SC, Brasil.Université de Paris, Institut Cochin, INSERM U1016, CNRS, Paris, France.Universidade Federal de Santa Catarina. Departamento de Farmacologia. Florianópolis, SC, Brasil / Universidade Federal de Santa Catarina. Departamento de Imunobiologia, Parasitologia e Microbiologia. Florianóplis, SC, Brasil.Background and Purpose: Neutrophil overstimulation plays a crucial role in tissue damage during severe infections. Because pathogen-derived neuraminidase (NEU) stimulates neutrophils, we investigated whether host NEU can be targeted to regulate the neutrophil dysregulation observed in severe infections. Experimental Approach: The effects of NEU inhibitors on lipopolysaccharide (LPS)- stimulated neutrophils from healthy donors or COVID-19 patients were determined by evaluating the shedding of surface sialic acids, cell activation, and reactive oxygen species (ROS) production. Re-analysis of single-cell RNA sequencing of respiratory tract samples from COVID-19 patients also was carried out. The effects of oseltamivir on sepsis and betacoronavirus-induced acute lung injury were evaluated in murine models. Key Results: Oseltamivir and zanamivir constrained host NEU activity, surface sialic acid release, cell activation, and ROS production by LPS-activated human neutrophils. Mechanistically, LPS increased the interaction of NEU1 with matrix metalloproteinase 9 (MMP-9). Inhibition of MMP-9 prevented LPS-induced NEU activity and neutrophil response. In vivo, treatment with oseltamivir fine-tuned neutrophil migration and improved infection control as well as host survival in peritonitis and pneumonia sepsis. NEU1 also is highly expressed in neutrophils from COVID-19 patients, and treatment of whole-blood samples from these patients with either oseltamivir or zanamivir reduced neutrophil overactivation. Oseltamivir treatment of intranasally infected mice with the mouse hepatitis coronavirus 3 (MHV-3) decreased lung neutrophil infiltration, viral load, and tissue damage. Conclusion and Implications: These findings suggest that interplay of NEU1–MMP-9 induces neutrophil overactivation. In vivo, NEU may serve as a host-directed target to dampen neutrophil dysfunction during severe infections.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/58090/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALAlexandreMorrot_etal_IOC_2022.pdfAlexandreMorrot_etal_IOC_2022.pdfapplication/pdf5816101https://www.arca.fiocruz.br/bitstream/icict/58090/2/AlexandreMorrot_etal_IOC_2022.pdf0939cad3288136dbe54d5faf10908bcbMD52icict/580902023-09-14 15:37:36.126oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-09-14T18:37:36Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.en_US.fl_str_mv Neuraminidase is a host-directed approach to regulate neutrophil responses in sepsis and COVID-19
title Neuraminidase is a host-directed approach to regulate neutrophil responses in sepsis and COVID-19
spellingShingle Neuraminidase is a host-directed approach to regulate neutrophil responses in sepsis and COVID-19
Formiga, Rodrigo de Oliveira
COVID-19
SARS-CoV-2
Sepsis
Metalloproteinase-9
Neuraminidase
Neutrófilo
Ácido siálico
Zanamivir
Oseltamivir
Sepse
COVID-19
Metalloproteinase-9
Neuraminidase
Neutrophil
SARS-CoV-2
Sialic acid
Zanamivir
Oseltamivir
Sepsis
title_short Neuraminidase is a host-directed approach to regulate neutrophil responses in sepsis and COVID-19
title_full Neuraminidase is a host-directed approach to regulate neutrophil responses in sepsis and COVID-19
title_fullStr Neuraminidase is a host-directed approach to regulate neutrophil responses in sepsis and COVID-19
title_full_unstemmed Neuraminidase is a host-directed approach to regulate neutrophil responses in sepsis and COVID-19
title_sort Neuraminidase is a host-directed approach to regulate neutrophil responses in sepsis and COVID-19
author Formiga, Rodrigo de Oliveira
author_facet Formiga, Rodrigo de Oliveira
Amaral, Flávia C.
Souza, Camila F.
Mendes, Daniel A. G. B.
Wanderley, Carlos W. S.
Lorenzini, Cristina B.
Santos, Adara A.
Antônia, Juliana
Farias, Lucas F.
Natale, Caio C.
Paula, Nicholas M.
Silva, Patricia C. S.
Fonseca, Fernanda R.
Aires, Luan
Heck, Nicole
Starick, Márick R.
Queiroz-Junior, Celso M.
Santos, Felipe R. S.
Souza, Filipe R. O. de
Costa, Vivian
Morrto, Alexandre
Van Weyenbergh, Johan
Sordi, Regina
Silva, Frederico Alisson
Cunha, Fernando Q.
Rocha, Edroaldo L.
Chollet-Martin, Silvie
Hurtado-Nedelec, Maria Margarita
Martin, Clémence
Burgel, Pierre-Régis
Mansur, Daniel S.
Maurici, Rosemeri
Macauley, Matthew S.
Báfica, André
Witko-Sarsat, Véronique
Spiller, Fernando
author_role author
author2 Amaral, Flávia C.
Souza, Camila F.
Mendes, Daniel A. G. B.
Wanderley, Carlos W. S.
Lorenzini, Cristina B.
Santos, Adara A.
Antônia, Juliana
Farias, Lucas F.
Natale, Caio C.
Paula, Nicholas M.
Silva, Patricia C. S.
Fonseca, Fernanda R.
Aires, Luan
Heck, Nicole
Starick, Márick R.
Queiroz-Junior, Celso M.
Santos, Felipe R. S.
Souza, Filipe R. O. de
Costa, Vivian
Morrto, Alexandre
Van Weyenbergh, Johan
Sordi, Regina
Silva, Frederico Alisson
Cunha, Fernando Q.
Rocha, Edroaldo L.
Chollet-Martin, Silvie
Hurtado-Nedelec, Maria Margarita
Martin, Clémence
Burgel, Pierre-Régis
Mansur, Daniel S.
Maurici, Rosemeri
Macauley, Matthew S.
Báfica, André
Witko-Sarsat, Véronique
Spiller, Fernando
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Formiga, Rodrigo de Oliveira
Amaral, Flávia C.
Souza, Camila F.
Mendes, Daniel A. G. B.
Wanderley, Carlos W. S.
Lorenzini, Cristina B.
Santos, Adara A.
Antônia, Juliana
Farias, Lucas F.
Natale, Caio C.
Paula, Nicholas M.
Silva, Patricia C. S.
Fonseca, Fernanda R.
Aires, Luan
Heck, Nicole
Starick, Márick R.
Queiroz-Junior, Celso M.
Santos, Felipe R. S.
Souza, Filipe R. O. de
Costa, Vivian
Morrto, Alexandre
Van Weyenbergh, Johan
Sordi, Regina
Silva, Frederico Alisson
Cunha, Fernando Q.
Rocha, Edroaldo L.
Chollet-Martin, Silvie
Hurtado-Nedelec, Maria Margarita
Martin, Clémence
Burgel, Pierre-Régis
Mansur, Daniel S.
Maurici, Rosemeri
Macauley, Matthew S.
Báfica, André
Witko-Sarsat, Véronique
Spiller, Fernando
dc.subject.other.en_US.fl_str_mv COVID-19
SARS-CoV-2
Sepsis
Metalloproteinase-9
Neuraminidase
Neutrófilo
Ácido siálico
Zanamivir
Oseltamivir
Sepse
topic COVID-19
SARS-CoV-2
Sepsis
Metalloproteinase-9
Neuraminidase
Neutrófilo
Ácido siálico
Zanamivir
Oseltamivir
Sepse
COVID-19
Metalloproteinase-9
Neuraminidase
Neutrophil
SARS-CoV-2
Sialic acid
Zanamivir
Oseltamivir
Sepsis
dc.subject.en.en_US.fl_str_mv COVID-19
Metalloproteinase-9
Neuraminidase
Neutrophil
SARS-CoV-2
Sialic acid
Zanamivir
Oseltamivir
Sepsis
description Universidade Federal de Santa Catarina. Departamento de Farmacologia. Florianópolis, SC, Brasil / Université de Paris, Institut Cochin, INSERM U1016, CNRS, Paris, France / Universidade Federal de Santa Catarina. Departamento de Imunobiologia, Parasitologia e Microbiologia. Florianóplis, SC, Brasil.
publishDate 2022
dc.date.issued.fl_str_mv 2022
dc.date.accessioned.fl_str_mv 2023-04-30T14:53:39Z
dc.date.available.fl_str_mv 2023-04-30T14:53:39Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv FORMIGA, Rodrigo de Oliveira et al. Neuraminidase is a host-directed approach to regulate neutrophil responses in sepsis and COVID-19. British Pharmacological Society, p. 1-22, 2023.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/58090
dc.identifier.issn.en_US.fl_str_mv 1476-5381
dc.identifier.doi.none.fl_str_mv 10.1111/bph.16013
identifier_str_mv FORMIGA, Rodrigo de Oliveira et al. Neuraminidase is a host-directed approach to regulate neutrophil responses in sepsis and COVID-19. British Pharmacological Society, p. 1-22, 2023.
1476-5381
10.1111/bph.16013
url https://www.arca.fiocruz.br/handle/icict/58090
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv British Pharmacological Society
publisher.none.fl_str_mv British Pharmacological Society
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/58090/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/58090/2/AlexandreMorrot_etal_IOC_2022.pdf
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
0939cad3288136dbe54d5faf10908bcb
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009235165839360